David Nathan, MD
Professor of Medicine, Harvard Medical School
Chief, Diabetes Unit Medical Service
Department of Molecular Biology
Dr. David M. Nathan is currently Director of the General Clinical Research Center and of the Diabetes Center at Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School.
With more than 200 articles in the medical literature, Dr. Nathan is an internationally recognized expert on diabetes and its complications.
Dr. Nathan focuses on the development of innovative therapies to treat type 1 and type 2 diabetes and to prevent its long-term complications. Dr. Nathan was a pioneer in the development of intensive therapies for diabetes and was one of the architects of the landmark Diabetes Control and Complications Trial.
He currently is the co-chairman of the Epidemiology of Diabetes Interventions and Complications Study in Type 1 diabetes and is the chairman of the Diabetes Prevention Program, an NIH-sponsored multicenter trial to prevent type 2 diabetes. This clinical trial has demonstrated that moderate weight loss and exercise delay the onset of Type 2 diabetes in those who are likely to get the disease.
Professional recognition during the past 10 years includes: Charles Best Award from American Diabetes Association (1994); Saul Horowitz, Jr. Memorial Award, for outstanding contributions in investigation and teaching, Mt. Sinai School of Medicine (1997); Excellence in Teaching Award, Primary Care, Mass General (1996-2002); American Association of Physicians (2001); and Outstanding Physician/Clinician Award, American Diabetes Association (2002)
MGH physician directory listing
View research publications